Global Amniotic Membrane Market Overview
The key driver impacting the amniotic membrane market is the rising number of cosmetics and plastic surgeries globally. the amniotic products are majorly utilized for reconstructive surgeries to reduce scarring and promote healing, thus boosting market demand in the forecast period. For instance, According to estimates from the American Society of Plastic Surgeons, in 2018 around 17.7 million minimally-invasive and surgical cosmetic procedures took place in the United States in a number that has increased gradually in the past five years. It is due to the rising number of individuals undergoing surgery to improve their visual appeal. Moreover, the increasing aging patient population with a high prevalence of eye disorder and the rise in amniotic membrane-based transplantations globally is also estimated to be a significant determinant that adds growth to the market.
According to Value Market Research, the global amniotic membrane market was valued at around USD 2,500 million in 2020 and is estimated to grow at a CAGR of about 15% during the forecast period of 2021 to 2027.
The rising cases of burn injuries and surgeries related to that globally are estimated to improve market demand in the forecast period as amniotic membranes are used for burn injury treatments and facilitate quick epithelialization and wound healing. It also helps in minimizing pain and makes possible easy movement of the affected area. also, the usage of this method is cost-effective as compared to allografts and xenografts. for instance, as per the World Health Organization, globally, around 180 000 deaths are caused by burns every year. The majority happen in middle and low -income nations. non-fatal burn injuries are considered the primary cause of morbidity. In India, around 1,000,000 people are severely or moderately burnt every year. as per the center for disease control and prevention (CDC), every year in the United States, about 1.1 million burn injuries need medical attention. The high usage of amniotic membranes for various indications such as the reconstruction of the conjunctiva surface, pterygium excisions, corneal ulcers, surgical wounds, pressure, and venous leg ulcers, is also boosting the market demand in the coming years. However, the rising healthcare cost may hamper the global amniotic membrane market in the long run. the current industry trends, such as the increasing R&D investments in the field of stem cell and regenerative medicine, and growing awareness programs for wound care treatment and management are expected to provide profitable market opportunities for the market players.
The amniotic membrane market is vast, with many local and global players. the key leaders follow several strategies to develop their market position, such as mergers, contracts, acquisitions, expansions, extending product portfolio, product innovations to improve their market share globally. The major players included in the report are Amnio Technology, Alliqua BioMedical, Inc, Applied Biologics LLC, DermaSciences, Human Regenerative Technologies, Amniox Medical, Inc, Katena Products, Inc, Skye Biologics, Inc, MiMedx Group, Inc, and Organogensis, Inc..
In this research report, the amniotic membrane market is segmented by enzyme, applications, end-user, and region.
Analysis by Enzyme:
By enzyme, the report is categorized into cryopreserved, and dehydrated. The cryopreserved segment dominates the enzyme segment with over 55% share in 2020. It is due to the growing usage of cryopreserved products in ocular surgeries, aid faster recovery and reduced inflammation of the eye. Moreover, the rising number of ocular surgeries and cosmetic surgeries contributes to the growth in the forecast period.
Analysis by Applications:
By applications, the report is categorized into surgical wounds, ophthalmology, and others. The surgical wounds dominate the application segment with over 30% share in 2020. It is due to the rising number of surgeries and prevalence of surgical & traumatic wounds and burns injuries across the globe. Moreover, growing awareness programs for wound care treatment and management contribute to the vast market demand in surgical wound applications in the forecast period.
Analysis by End-User:
By end-user, the report is categorized in hospitals, ambulatory surgical centers (ASCS), specialty clinics, and research and academic institutes. There is a considerable growth observed in the hospital segment in the forecast period. It is because hospitals are the primary care settings that provide comfortable treatment for an extensive range of diseases. Moreover, frequent visits by patients and its ability to cater to a varied range of surgical interventions contribute to the vast market demand from the hospital sector in the forecast period.
Analysis by Region:
In the regional outlook of the global amniotic membrane market, the North America region dominates with a 33% market share during the forecast period. It is due to the presence of well-developed healthcare infrastructure and leading companies in the U.S. Moreover, the growing adoption of advanced technologies and rising healthcare expenditure contribute to the development of the amniotic membrane market across North America.
Market Segmentation covered in the Report:
By Enzyme
By Application
- Surgical Wounds
- Ophthalmology
- Others
By End-User
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Research Institutes and Academic Institutes
By Region
- North America
- Europe
- The Asia Pacific
- Latin America
- The Middle East and Africa
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . AMNIOTIC MEMBRANE – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 By Enzyme
3.7.2 By Application
3.7.3 By End-User
3.7.4 By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak
5.1.1. Direct Impact on Production
5.1.2. Supply Chain and Market Disruption
5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis
6 . GLOBAL AMNIOTIC MEMBRANE MARKET ANALYSIS BY ENZYME
6.1 Overview by Enzyme
6.2 Historical and Forecast Data
6.3 Analysis by Enzyme
6.4 Cryopreserved Market by Regions
6.5 Dehydrated Market by Regions
7 . GLOBAL AMNIOTIC MEMBRANE MARKET ANALYSIS BY APPLICATION
7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Surgical Wounds Market by Regions
7.5 Ophthalmology Market by Regions
7.6 Others Market by Regions
8 . GLOBAL AMNIOTIC MEMBRANE MARKET ANALYSIS BY END-USER
8.1 Overview by End-User
8.2 Historical and Forecast Data
8.3 Analysis by End-User
8.4 Hospitals Market by Regions
8.5 Ambulatory Surgical Centers Market by Regions
8.6 Specialty Clinics Market by Regions
8.7 Research Institutes and Academic Institutes Market by Regions
9 . GLOBAL AMNIOTIC MEMBRANE MARKET ANALYSIS BY GEOGRAPHY
9.1. Regional Outlook
9.2. Introduction
9.3. North America
9.3.1. Overview, Historic and Forecast Data
9.3.2. North America By Segment
9.3.3. North America By Country
9.3.4. United State
9.3.5. Canada
9.3.6. Mexico
9.4. Europe
9.4.1. Overview, Historic and Forecast Data
9.4.2. Europe by Segment
9.4.3. Europe by Country
9.4.4. United Kingdom
9.4.5. France
9.4.6. Germany
9.4.7. Italy
9.4.8. Russia
9.4.9. Rest Of Europe
9.5. Asia Pacific
9.5.1. Overview, Historic and Forecast Data
9.5.2. Asia Pacific by Segment
9.5.3. Asia Pacific by Country
9.5.4. China
9.5.5. India
9.5.6. Japan
9.5.7. South Korea
9.5.8. Australia
9.5.9. Rest Of Asia Pacific
9.6. Latin America
9.6.1. Overview, Historic and Forecast Data
9.6.2. Latin America by Segment
9.6.3. Latin America by Country
9.6.4. Brazil
9.6.5. Argentina
9.6.6. Peru
9.6.7. Chile
9.6.8. Rest of Latin America
9.7. Middle East & Africa
9.7.1. Overview, Historic and Forecast Data
9.7.2. Middle East & Africa by Segment
9.7.3. Middle East & Africa by Country
9.7.4. Saudi Arabia
9.7.5. UAE
9.7.6. Israel
9.7.7. South Africa
9.7.8. Rest Of Middle East And Africa
10 . COMPETITIVE LANDSCAPE OF THE AMNIOTIC MEMBRANE COMPANIES
10.1. Amniotic Membrane Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments
11 . COMPANY PROFILES OF AMNIOTIC MEMBRANE INDUSTRY
11.1. Company Share Analysis
11.2. Market Concentration Rate
11.3. Amnio Technology
11.3.1. Company Overview
11.3.2. Financials
11.3.3. Products
11.3.4. Recent Developments
11.4. Alliqua BioMedical, Inc
11.4.1. Company Overview
11.4.2. Financials
11.4.3. Products
11.4.4. Recent Developments
11.5. Applied Biologics LLC
11.5.1. Company Overview
11.5.2. Financials
11.5.3. Products
11.5.4. Recent Developments
11.6. DermaSciences
11.6.1. Company Overview
11.6.2. Financials
11.6.3. Products
11.6.4. Recent Developments
11.7. Human Regenerative Technologies
11.7.1. Company Overview
11.7.2. Financials
11.7.3. Products
11.7.4. Recent Developments
11.8. Amniox Medical, Inc
11.8.1. Company Overview
11.8.2. Financials
11.8.3. Products
11.8.4. Recent Developments
11.9. Katena Products, Inc
11.9.1. Company Overview
11.9.2. Financials
11.9.3. Products
11.9.4. Recent Developments
11.10. Skye Biologics, Inc
11.10.1. Company Overview
11.10.2. Financials
11.10.3. Products
11.10.4. Recent Developments
11.11. MiMedx Group, Inc
11.11.1. Company Overview
11.11.2. Financials
11.11.3. Products
11.11.4. Recent Developments
11.12. Organogensis, Inc
11.12.1. Company Overview
11.12.2. Financials
11.12.3. Products
11.12.4. Recent Developments
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- COVID-19 Impact Analysis by Production, Import, Export and Demand
- Pre V/S Post COVID-19
- Estimated Impact Of The Coronavirus (Covid-19) Epidemic
- COVID-19: Micro and Macro Factor Analysis
- Analysis by Enzyme (USD MN)
- Cryopreserved Market by Geography (USD MN)
- Dehydrated Market by Geography (USD MN)
- Analysis Market by Application (USD MN)
- Surgical Wounds Market by Geography (USD MN)
- Ophthalmology Market by Geography (USD MN)
- Others Market by Geography (USD MN)
- Analysis by End-User (USD MN)
- Hospitals Market by Geography (USD MN)
- Ambulatory Surgical Centers Market by Geography (USD MN)
- Specialty Clinics Market by Geography (USD MN)
- Research Institutes and Academic Institutes Market by Geography (USD MN)
- Global Amniotic Membrane Market by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisiton
LIST OF FIGURES
- Research Scope of Amniotic Membrane Report
- Market Research Process
- Market Research Methodology
- Global Amniotic Membrane Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Enzyme
- Market Attractiveness Analysis by Application
- Market Attractiveness Analysis by End-User
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Enzyme (USD MN)
- Cryopreserved Market by Geography (USD MN)
- Dehydrated Market by Geography (USD MN)
- Global Market Analysis by Application (USD MN)
- Surgical Wounds Market by Geography (USD MN)
- Ophthalmology Market by Geography (USD MN)
- Others Market by Geography (USD MN)
- Global Market Analysis by End-User (USD MN)
- Hospitals Market by Geography (USD MN)
- Ambulatory Surgical Centers Market by Geography (USD MN)
- Specialty Clinics Market by Geography (USD MN)
- Research Institutes and Academic Institutes Market by Geography (USD MN)
- Global Market by Revenue
- North America Market by Revenue
- Europe Market by Revenue
- Asia Pacific Market by Revenue
- Latin America Market by Revenue
- Middle East & Africa Market by Revenue
- Recent Development in Industry
- Company Market Share Analysis
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.